{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:05:40Z","timestamp":1785186340914,"version":"3.55.0"},"reference-count":25,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Chirality"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>A robust chiral high\u2010performance liquid chromatography (HPLC) method was established to separate and quantify the enantiomeric impurity (3S, 4S, 5R) in oseltamivir phosphate. A new sample preparation approach was used, involving the solvent extraction method to remove phosphate salt from the drug, thereby preventing the column's clogging and confirming method repeatability. Thin\u2010layer chromatography (TLC) was employed to identify oseltamivir in the organic layer, while <jats:sup>31<\/jats:sup>P nuclear magnetic resonance (NMR) spectroscopy and the molybdenum blue method were used to confirm the presence of phosphate in the aqueous layer. An ion\u2010pair reversed\u2010phase HPLC method with indirect UV detection was utilized to quantify the phosphate in both the organic and aqueous phases. Chromatographic separation of enantiomeric impurity (3S, 4S, 5R) from oseltamivir phosphate drug substances (3R, 4R, 5S) was accomplished using a Chiralpak IC\u20103 column with a mobile phase consisting of n\u2010hexane, methanol, isopropyl alcohol, and diethyl amine (85:10:5:0.2, <jats:italic>v\/v\/v\/v<\/jats:italic>) at a flow rate of 0.6\u2009mL\/min and a detection wavelength of 225\u2009nm. The selectivity of method is clearly proved by separating the impurity from oseltamivir phosphate drug substance, with a resolution of more than 3.0. The method displayed exceptional linearity over a range of 0.035\u20130.300%<jats:italic>w\/w<\/jats:italic>, with limits of detection of 0.005%<jats:italic>w\/w<\/jats:italic> and quantification of 0.035%<jats:italic>w\/w<\/jats:italic>. Consistent recovery rates were obtained between 91% and 94%, and the analytical solution remains stable for up to 72\u2009h at 2\u00b0C\u20138\u00b0C.<\/jats:p>","DOI":"10.1002\/chir.70034","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T22:33:49Z","timestamp":1746657229000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantification of Oseltamivir Phosphate Enantiomeric Impurity by Chiral HPLC Method With the Aid of Solvent Extraction and Phosphate Salt\u2010Out Method"],"prefix":"10.1002","volume":"37","author":[{"given":"Torati","family":"Srinivas","sequence":"first","affiliation":[{"name":"Department of Chemistry, GITAM School of Science GITAM (Deemed to be University)  Visakhapatnam AP India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8673-474X","authenticated-orcid":false,"given":"K.\u00a0V.\u00a0N.\u00a0Suresh","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Chemistry, GITAM School of Science GITAM (Deemed to be University)  Visakhapatnam AP India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Challa","family":"Madhavi","sequence":"additional","affiliation":[{"name":"Department of Chemistry, GITAM School of Science GITAM (Deemed to be University)  Visakhapatnam AP India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.\u00a0Kiranmai","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, GITAM School of Science GITAM (Deemed to be University)  Visakhapatnam AP India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.1.13"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/11534730\u2010000000000\u201000000"},{"key":"e_1_2_8_4_1","unstructured":"European Pharmacopoeia (2021); Edition (10):3437\u20103439."},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1039\/c6ob02673g"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1039\/C3OB42069H"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejoc.200800033"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.59566\/IJBS.2006.2085"},{"key":"e_1_2_8_9_1","unstructured":"\u201cICH Topic Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products Chemical Substances \u201dhttps:\/\/database.ich.org\/sites\/default\/files\/Q6A%20Guideline.pdf."},{"key":"e_1_2_8_10_1","unstructured":"\u201cInternational Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use \u201d ICH Harmonized Tripartite Guideline decision tree #5 https:\/\/database.ich.org\/sites\/default\/files\/Q6A%20Decision%20Tree.pdf."},{"key":"e_1_2_8_11_1","unstructured":"ICH Topic Q3 (A) & Q3 (B) \u201cInternational Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use \u201dhttps:\/\/database.ich.org\/sites\/default\/files\/Q3A%28R2%29%20Guideline.pdf."},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0021\u20109673(00)00532\u2010x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/chir.20066"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/chir.20287"},{"issue":"1","key":"e_1_2_8_15_1","first-page":"1","article-title":"Degradation Behavior of Oseltamivir Phosphate Under Various Stress Conditions Using Stability\u2010Indicating HPLC Method","volume":"3","author":"Upmanyu N.","year":"2019","journal-title":"Journal of Pharmaceutical Science and Technology Management"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/327351"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.9734\/BJPR\/2017\/33044"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43094\u2010024\u201000666\u20106"},{"key":"e_1_2_8_19_1","doi-asserted-by":"crossref","unstructured":"United States Pharmacopeia \u201cUSP Monographs Oseltamivir Phosphate Rockville \u201d MD: United States Pharmacopeia (2023) https:\/\/doi.org\/10.31003\/USPNF_M58970_04_01.","DOI":"10.31003\/USPNF_M58970_04_01"},{"key":"e_1_2_8_20_1","unstructured":"SKVladimir \u201cAdvances in Development of Solvents for Liquid\u2013Liquid Extraction \u201d Chapter\u00a013.2012;https:\/\/doi.org\/10.1016\/B978\u20100\u2010444\u201053778\u20102.10013\u20105."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.desal.2013.06.008"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1039\/D0RA06361D"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.23887\/jst\u2010undiksha.v7i2.13940"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/mrc.5429"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoac\/93.4.1113"},{"key":"e_1_2_8_26_1","unstructured":"International Conference on Harmonisation \u201cGuideline on Validation of Analytical Procedures: Text and Methodology Q2 (R1) \u201d (2005)."}],"container-title":["Chirality"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/chir.70034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T06:36:18Z","timestamp":1747290978000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/chir.70034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1002\/chir.70034"],"URL":"https:\/\/doi.org\/10.1002\/chir.70034","archive":["Portico"],"relation":{},"ISSN":["0899-0042","1520-636X"],"issn-type":[{"value":"0899-0042","type":"print"},{"value":"1520-636X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2025-01-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70034"}}